- Home
- MG vs PRQR Comparison
MG vs PRQR Comparison
Compare MG & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MG
- PRQR
- Stock Information
- Founded
- MG 1978
- PRQR 2012
- Country
- MG United States
- PRQR Netherlands
- Employees
- MG N/A
- PRQR N/A
- Industry
- MG Military/Government/Technical
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- MG Consumer Discretionary
- PRQR Health Care
- Exchange
- MG Nasdaq
- PRQR Nasdaq
- Market Cap
- MG 251.6M
- PRQR 179.1M
- IPO Year
- MG 2009
- PRQR 2014
- Fundamental
- Price
- MG $8.05
- PRQR $2.35
- Analyst Decision
- MG
- PRQR Strong Buy
- Analyst Count
- MG 0
- PRQR 8
- Target Price
- MG N/A
- PRQR $8.88
- AVG Volume (30 Days)
- MG 162.4K
- PRQR 357.1K
- Earning Date
- MG 07-30-2025
- PRQR 08-07-2025
- Dividend Yield
- MG N/A
- PRQR N/A
- EPS Growth
- MG N/A
- PRQR N/A
- EPS
- MG 0.47
- PRQR N/A
- Revenue
- MG $706,813,000.00
- PRQR $21,212,711.00
- Revenue This Year
- MG $0.81
- PRQR N/A
- Revenue Next Year
- MG $2.93
- PRQR N/A
- P/E Ratio
- MG $17.22
- PRQR N/A
- Revenue Growth
- MG N/A
- PRQR 85.91
- 52 Week Low
- MG $7.06
- PRQR $1.07
- 52 Week High
- MG $12.44
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- MG 52.70
- PRQR 66.90
- Support Level
- MG $7.97
- PRQR $2.10
- Resistance Level
- MG $8.37
- PRQR $2.18
- Average True Range (ATR)
- MG 0.20
- PRQR 0.13
- MACD
- MG 0.05
- PRQR 0.01
- Stochastic Oscillator
- MG 64.44
- PRQR 56.92
About MG Mistras Group Inc
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.